HCPCS code M0244 — Casirivi and imdevi inj hm. Status: Deleted. Effective Dec 13, 2024. Source: CMS HCPCS Level II.

M0244

Deleted

Casirivi and imdevi inj hm

Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency

Code M0244 has been deleted from the HCPCS Level II set.

Termination date: Dec 12, 2024. Claims with a date of service on or after this day will be denied under this code.

No successor code has been identified. Consult the CMS HCPCS Update Summary for guidance.

Category: Medical Services
Section: M-codes: Medical Services
Effective: Dec 13, 2024
Terminated: Dec 12, 2024
Code type: alphanumeric

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • Deleted 2024-Q4
    Casirivi and imdevi inj hm
  • New Code 2024-Q4
    Casirivi and imdevi inj hm